Our results showed significantly higher levels of CD3/CD69-, CD8/CD69- and CD19/CD69-positive PBMCs as well as within CD3+ cells present in patients with psoriasis when compared to the healthy control group, which is in agreement with the above findings (Table 3). This evidence concerns the gene CD19 and psoriasis.